Offer - Urjas Oil for just ₹ 1 X
Panarol, a prescription drug, is manufactured in various forms such as Tablet. Arrhythmia are some of its major therapeutic uses. Secondary and off-label uses of Panarol have also been mentioned below.
The optimal dosage of Panarol is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Panarol include Shortness of Breath, Cough, Trembling. Some other side effects of Panarol have been listed ahead. Normally, these side effects of Panarol are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Panarol is Severe for pregnant women and Severe for women who are breastfeeding. In addition, Panarol's effects on the liver, heart and kidney are discussed below in the Panarol related warnings section.
Panarol can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Panarol in conditions like Heart Failure, Heart Disease. Other conditions have been mentioned below in the Panarol contraindications section.
Drug interactions for Panarol have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Panarol is not safe while driving, and is not addiction.
Panarol is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Panarol safe for pregnant women?
Panarol can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Panarol safe during breastfeeding?
Panarol should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Panarol on the Kidneys?
Panarol is not harmful for kidneys.
What is the effect of Panarol on the Liver?
Using Panarol does not have any harmful effects on the liver.
What is the effect of Panarol on the Heart?
Very few cases of side effects of Panarol on the heart have been reported.
Panarol should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Panarol unless your doctor advises you to do so -
Is this Panarol habit forming or addictive?
Forming a habit of Panarol has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Panarol, you should not drive or work on any heavy machine, as Panarol can make you drowsy.
Is it safe?
Yes, but take Panarol only as per medical advice.
Is it able to treat mental disorders?
Panarol is unable to treat or cure mental disorders.
Interaction between Food and Panarol
Taking Panarol with food can show serious side effects. Consult the doctor to avoid this.
Interaction between Alcohol and Panarol
Information about the interaction of Panarol and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cordarone® (amiodarone HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 533-534
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 141-144